The following is a reconciliation of basic and diluted earnings per share for the years ended December 31, 2024, 2023 and 2022: | | | | | | | | | | | | | | | | | | | In millions, except per share amounts | 2024 | | 2023 | | 2022 | | Numerator for earnings per share calculation: | | | | | | | | | | | | | | | | | | | | | | | | | Net income attributable to CVS Health | $ | 4,614 | | | $ | 8,344 | | | $ | 4,311 | | | | | | | | | Denominator for earnings per share calculation: | | | | | | | Weighted average shares, basic | 1,259 | | | 1,285 | | | 1,312 | | | Restricted stock units and performance stock units | 2 | | | 3 | | | 6 | | | Stock options and SARs | 1 | | | 2 | | | 5 | | | Weighted average shares, diluted | 1,262 | | | 1,290 | | | 1,323 | | | | | | | | | Earnings per share: | | | | | | | Basic | $ | 3.67 | | | $ | 6.49 | | | $ | 3.29 | | | Diluted | $ | 3.66 | | | $ | 6.47 | | | $ | 3.26 | |
|